2026. Design and In Silico Evaluation of Novel 1,3,4-Oxadiazole Derivatives as Potential CYP51B Inhibitors Against Aspergillus fumigatus. Al Mustansiriyah Journal of Pharmaceutical Sciences. 26, 3 (Sep. 2026), 302–315. DOI:https://doi.org/10.32947/ajps.v26i3.1420.